Q4 2025 Personalis Inc Earnings Call Transcript

Feb 26, 2026 / 10:00 PM GMT

Release Date Price: $9.03 (+8.66%)

Transcript 10-K8-K

Key Points

Positve

Personalis Inc (PSNL) achieved significant clinical growth with a 329% year-over-year increase in clinical tests delivered in Q4 2025.
The company secured two Medicare coverage decisions for breast and lung cancer, validating the value of their MRD technology.
Personalis Inc (PSNL) reported a 239% growth in biopharma MRD revenue over the prior year, indicating strong demand for their services.
The company has a strong cash position with $240 million in cash and short-term investments, providing a solid financial foundation.
Personalis Inc (PSNL) is expanding its commercial footprint with plans to double its sales representatives to drive further growth.

Negative

Personalis Inc (PSNL) experienced a planned $19.5 million decline in revenue from legacy contracts, impacting overall revenue growth.
Gross margins were compressed to 11% in Q4 2025, with expectations of continued margin dilution into 2026 due to unreimbursed costs.
The company reported a net loss of $23.8 million for Q4 2025, reflecting increased operating expenses and investment in growth.
Personalis Inc (PSNL) is heavily reliant on future reimbursement coverage to improve margins and achieve profitability.
The biopharma sector remains unstable, with no major resurgence in demand for translational research, affecting revenue predictability.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

PSNL.OQ - Personalis Inc
Q4 2025 Personalis Inc Earnings Call
Feb 26, 2026 / 10:00PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Greetings and welcome to the Britanelli 4th quarter 2025 earnings conference. At this time, all participants are in a listen-only mode.

A brief question-and-answer session will follow the formal presentation.

If anyone should require operator assistance during the conference, please press and then 0 on your telephone keypad.

As a reminder, this conference is being recorded.

It is now my pleasure to introduce your host, Caroline Corner.

Thank you. You may begin.

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------------------------------------------
Thank you, operator. Welcome to

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

7-Day Free Trial · Cancel Anytime

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.